Insulin undergoes agglomeration with (subtle) changes
in its biochemical
environment, including acidity, application of heat, ionic imbalance,
and exposure to hydrophobic surfaces. The therapeutic impact of such
unwarranted insulin agglomeration is unclear and needs further evaluation.
A systematic investigation was conducted on recombinant human insulinwith
or without labeling with fluorescein isothiocyanatewhile preparing
insulin suspensions (0.125, 0.25, and 0.5 mg/mL) at pH 3. The suspensions
were incubated (37 °C) and analyzed at different time points
(t = 2, 4, 24, 48, and 72 h). Transmission electron
microscopy and nanoparticle tracking analysis identified colloidally
stable (zeta potential 15 ± 5 mV) spherical agglomerates of unlabeled
insulin (100–500 nm). Circular dichroism established the preservation
of insulin’s secondary structure rich in α-helices despite
exposure to an acidic environment (pH 3) for 72 h. Furthermore, fluorescence
lifetime imaging microscopy illustrated an acidic core inside these
spherical agglomerates, while the acidity gradually lessened toward
the periphery. Some of these smaller agglomerates fused to form larger
chunks with discrete zones of acidity. The data indicated a primary
nucleation-driven mechanism of acid-induced insulin agglomeration
under physiologically relevant conditions.